Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins
Authors:
- Wolfgang H. CaselmannWCWolfgang H. Caselmann
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 19 (2) , 312-315
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Analysis of the P53 Tumor–Suppressor Gene in Hepatocellular Carcinomas From BritainHepatology, 1992
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Cell, 1992
- p53, guardian of the genomeNature, 1992
- Hepatocellular carcinomaJournal of Hepatology, 1992
- A Chromosome 17:7 Translocation Is Associated With A Hepatitis B Virus Dna Integration in Human Hepatocellular Carcinoma DnaHepatology, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- Alterations in the structural gene and the expression of p53 in rat liver tumors induced by aflatoxin B1Molecular Carcinogenesis, 1992
- Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern AfricaNature, 1991
- Different Tumor-Derived p53 Mutants Exhibit Distinct Biological ActivitiesScience, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989